FDA gadolinium alert

The FDA along with the ACR has stayed on top of the Gadolinium concerns of many, in the last year. This latest update is now asking all of the Gadolinium pharmaceutical companies to change the packaging to warn about NSF. The FDA has provided some information for Healthcare Providers to better understand and to handle the complexities of this patient population. They have also set-up some FAQ for people.